BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31926145)

  • 1. Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics).
    Özenver N; Efferth T
    Biochem Pharmacol; 2020 Jun; 176():113792. PubMed ID: 31926145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
    Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
    Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual role of iNOS in cancer.
    Vannini F; Kashfi K; Nath N
    Redox Biol; 2015 Dec; 6():334-343. PubMed ID: 26335399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase: Regulation, structure, and inhibition.
    Cinelli MA; Do HT; Miley GP; Silverman RB
    Med Res Rev; 2020 Jan; 40(1):158-189. PubMed ID: 31192483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases?
    Tinker AC; Wallace AV
    Curr Top Med Chem; 2006; 6(2):77-92. PubMed ID: 16454760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
    Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
    Bonnefous C; Payne JE; Roppe J; Zhuang H; Chen X; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Severance D; Walsh JP; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
    J Med Chem; 2009 May; 52(9):3047-62. PubMed ID: 19374401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.
    Pannu R; Singh I
    Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible nitric oxide synthase: Good or bad?
    Lind M; Hayes A; Caprnda M; Petrovic D; Rodrigo L; Kruzliak P; Zulli A
    Biomed Pharmacother; 2017 Sep; 93():370-375. PubMed ID: 28651238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
    López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
    Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase inhibitors: A comprehensive update.
    Minhas R; Bansal Y; Bansal G
    Med Res Rev; 2020 May; 40(3):823-855. PubMed ID: 31502681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of inducible nitric oxide synthase (iNOS) in immune-functioning of Paphia malabarica (Chemnitz, 1782).
    Gajbhiye DS; Khandeparker L
    Fish Shellfish Immunol; 2019 Jan; 84():384-389. PubMed ID: 30308295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.
    Chayah M; Carrión MD; Gallo MA; Jiménez R; Duarte J; Camacho ME
    ChemMedChem; 2015 May; 10(5):874-82. PubMed ID: 25801086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for Potential Inducible Nitric Oxide Synthase Inhibitors with Favorable ADMET Profiles for the Therapy of Helicobacter pylori Infections.
    Rodrigues RP; Ardisson JS; Ribeiro Gonçalves RC; Oliveira TB; Barreto da Silva V; Kawano DF; Kitagawa RR
    Curr Top Med Chem; 2019; 19(30):2795-2804. PubMed ID: 31721712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on the pulmonary hypertensive response to microparticle injections in broilers.
    Wideman RF; Bowen OT; Erf GF; Chapman ME
    Poult Sci; 2006 Mar; 85(3):511-27. PubMed ID: 16553284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
    Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
    Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
    Maccallini C; Di Matteo M; Gallorini M; Montagnani M; Graziani V; Ammazzalorso A; Amoia P; De Filippis B; Di Silvestre S; Fantacuzzi M; Giampietro L; Potenza MA; Re N; Pandolfi A; Cataldi A; Amoroso R
    Eur J Med Chem; 2018 May; 152():53-64. PubMed ID: 29689474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.
    Young RJ; Alderton W; Angell AD; Beswick PJ; Brown D; Chambers CL; Crowe MC; Dawson J; Hamlett CC; Hodgson ST; Kleanthous S; Knowles RG; Russell LJ; Stocker R; Woolven JM
    Bioorg Med Chem Lett; 2011 May; 21(10):3037-40. PubMed ID: 21482467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a natural product-like iNOS inhibitor by molecular docking with potential neuroprotective effects in vivo.
    Zhong HJ; Liu LJ; Chong CM; Lu L; Wang M; Chan DS; Chan PW; Lee SM; Ma DL; Leung CH
    PLoS One; 2014; 9(4):e92905. PubMed ID: 24690920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.